Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Association between vitamin D and hepatitis C virus infection: a meta-analysis.

Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M.

World J Gastroenterol. 2013 Sep 21;19(35):5917-24. doi: 10.3748/wjg.v19.i35.5917. Review.

2.

Vitamin D status and viral response to therapy in hepatitis C infected children.

Eltayeb AA, Abdou MA, Abdel-aal AM, Othman MH.

World J Gastroenterol. 2015 Jan 28;21(4):1284-91. doi: 10.3748/wjg.v21.i4.1284.

3.

Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.

Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK.

J Hepatol. 2014 Dec;61(6):1247-52. doi: 10.1016/j.jhep.2014.08.004. Epub 2014 Aug 15. Review.

PMID:
25135863
4.

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.

Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C.

J Hepatol. 2011 May;54(5):887-93. doi: 10.1016/j.jhep.2010.08.036. Epub 2011 Jan 20.

PMID:
21145801
5.

Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.

Yamada G, Iino S, Okuno T, Omata M, Kiyosawa K, Kumada H, Hayashi N, Sakai T.

Clin Drug Investig. 2008;28(1):9-16. Erratum in: Clin Drug Investig. 2008;28(4):210.

PMID:
18081356
6.

Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients.

Nimer A, Mouch A.

World J Gastroenterol. 2012 Feb 28;18(8):800-5. doi: 10.3748/wjg.v18.i8.800.

7.

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P.

Hepatology. 2011 Apr;53(4):1118-26. doi: 10.1002/hep.24201.

PMID:
21480318
8.

In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.

Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ.

Am J Clin Nutr. 2013 Aug;98(2):423-9. doi: 10.3945/ajcn.112.048785. Epub 2013 Jun 5.

9.

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.

Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.

AIDS. 2013 Jan 14;27(2):227-32. doi: 10.1097/QAD.0b013e32835aa161.

PMID:
23238552
10.

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.

Ladero JM, Torrejón MJ, Sánchez-Pobre P, Suárez A, Cuenca F, de la Orden V, Devesa MJ, Rodrigo M, Estrada V, López-Alonso G, Agúndez JA.

Ann Hepatol. 2013 Mar-Apr;12(2):199-204.

11.

Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.

Galán RJ, Cidoncha EC, Martin MF, Rodriguez CC, Almeida CV, Verdugo RM.

J Manag Care Pharm. 2013 Jul-Aug;19(6):448-53.

12.

Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.

Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N.

World J Gastroenterol. 2011 Dec 21;17(47):5184-90. doi: 10.3748/wjg.v17.i47.5184.

13.

Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.

Nilsson J, Weiland O.

Scand J Infect Dis. 2010 Jul;42(6-7):533-9. doi: 10.3109/00365541003621486.

PMID:
20214543
14.

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.

Peribañez-Gonzalez M, da Silva MH, Vilar FC, Seixas-Santos Nastri AC, Ferreira PA, Focaccia R, Mendes Correa MC.

Ann Hepatol. 2013 Mar-Apr;12(2):228-35.

15.

Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

Feng B, Zhang W, Luo BF, Song GJ, Wang J, Jin Q, Qin H, Wei L.

World J Gastroenterol. 2014 Nov 7;20(41):15387-97. doi: 10.3748/wjg.v20.i41.15387. Review.

16.
17.

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.

Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, Souberbielle JC, Cacoub P.

J Hepatol. 2011 Oct;55(4):756-61. doi: 10.1016/j.jhep.2011.01.041. Epub 2011 Feb 18.

PMID:
21334402
18.

Sustained virological response according to the type of early virological response in HCV and HCV/HIV.

Lerias de Almeida PR, Alves de Mattos A, Valle Tovo C.

Ann Hepatol. 2010 Apr-Jun;9(2):150-5.

PMID:
20526007
19.

Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.

Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T.

Ther Apher Dial. 2014 Dec;18(6):603-11. doi: 10.1111/1744-9987.12189. Epub 2014 Sep 4.

PMID:
25196061
20.

Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients.

Melo-Villar L, Lampe E, de Almeida AJ, de P Scalioni L, Lewis-Ximenez LL, Miguel JC, Del Campo JA, Ranchal I, Villela-Nogueira CA, Romero-Gomez M.

Ann Hepatol. 2015 Jul-Aug;14(4):457-63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk